Form D · Biotechnology
Beacon Biomedical Inc.
Phoenix, AZ · CIK 0001677022
Offering snapshot reported Sep 20, 2021 · SEC filing
- Reported sold
- $523K Offering amount: $1.6M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 20, 2021 | Amendment | $523,444 | No comparison | Not reported | SEC filing |
| May 22, 2019 | Amendment | $366,648 | $341,648vs Mar 22, 2018 | 12 | SEC filing |
| Mar 22, 2018 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Jul 28, 2017 | Amendment | $750,000 | $725,000vs Jun 14, 2016 | 19 | SEC filing |
| Jun 14, 2016 | Initial | $25,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-308353
Source: Form D, filed Sep 20, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dirk Beth | Director |
| F. Randall Grimes | Director, Executive |
| Andrew Lombard | Director |
| Donald F. Weber | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
275 N. Gateway Drive Suite 149
Phoenix, AZ, 85034
Phoenix, AZ, 85034